Xeris Pharmaceuticals, Inc.
Updated Filing received by DOL
Xeris Pharmaceuticals, Inc., a manufacturing — chemical, wood, plastics employer in Chicago, Illinois, reported 397 participants in its health and welfare plan for plan year 2025. Its Form 5500 shows 11 insurance contracts with no premium reported and $320,364 in broker commissions and fees. The plan is a mix of insured and self-funded coverage. The Department of Labor received the filing on July 21, 2026, before the deadline.
Who was paid on Xeris Pharmaceuticals, Inc.'s plan
Schedule A, Part I lists each broker or agent paid on each insurance contract and the amount. Totals below add every contract Xeris Pharmaceuticals, Inc. filed for 2025.
| Broker or agent | Commissions | Fees | Total | Contracts |
|---|---|---|---|---|
| Verus Insurance Services, LLC · Granite Bay, CA | $315,407 | $4,957 | $320,364 | 11 |
Source: DOL Form 5500 Schedule A, Part I (broker commissions and fees), plan year 2025, as published in EBSA's 2025 "Latest" dataset. Part I names whoever the carrier paid, which can be a firm or an individual agent; both are public record. Amounts exclude pay from carriers not tied to a listed contract.
Insurance contracts and carriers
Every insurance contract reported on Schedule A: carrier, what it covers, people covered at year end, earned premium, and broker compensation.
| Carrier · coverage | Covered | Premium | Broker pay | Rate |
|---|---|---|---|---|
| United of Omaha Life Insurance Companycoverage not coded | 19 | — | $3,379 | — |
| Eyemed Vision Carevision | 950 | — | $10,225 | — |
| United of Omaha Life Insurance Companylife | 431 | — | $6,669 | — |
| United of Omaha Life Insurance Companylife | 129 | — | $9,690 | — |
| United of Omaha Life Insurance Companyshort-term disability | 18 | — | $822 | — |
| Delta Dental of Illinoisdental | 395 | — | $12,324 | — |
| United of Omaha Life Insurance Companycoverage not coded | 41 | — | $2,379 | — |
| Bluecross Blueshield of Illinoishealth | 907 | — | $236,117 | — |
| United of Omaha Life Insurance Companyshort-term disability | 431 | — | $23,226 | — |
| United of Omaha Life Insurance Companylong-term disability | 431 | — | $12,567 | — |
| United of Omaha Life Insurance Companycoverage not coded | 62 | — | $2,966 | — |
Source: DOL Form 5500 Schedule A, plan year 2025. Self-funded medical coverage has no premium; amounts shown for it are stop-loss or administrative contracts.
How Xeris Pharmaceuticals, Inc. compares
Medians across employers for plan year 2024, the most recent complete year. Commission rates use fully insured medical contracts only; dollar medians use every employer that disclosed broker pay.
Not computable: no insured medical premium on the filing.
Source: BenefitsLedger benchmarks from 58,547 employer health plans with 100 or more participants, plan year 2024. Methodology.
Year over year
| 2024 | 2025 | Change | |
|---|---|---|---|
| Participants | 380 | 397 | +4.5% |
| Premiums filed | $0 | $0 | not comparable |
| Broker commissions + fees | $257,218 | $320,364 | +24.5% |
| Commission rate | — | — | — |
Source: DOL Form 5500 filings for plan years 2024 and 2025.
Filings and timeliness
Plans this employer filed under its EIN with a health benefit code. Large plans are due seven months after the plan year ends, or two and a half months later with an extension; amended filings carry the amendment date, so no timing is asserted for them.
| Plan | Plan year end | Received by DOL | Timing | Participants |
|---|---|---|---|---|
| Xeris Pharmaceuticals, Inc. Welfare Benefits Plan#501 · insurance, general assets | December 31, 2025 | July 21, 2026 | before deadline | 397 |
Source: DOL Form 5500 Part I and signature dates; "late" means received after the extended deadline (the 15th day of the tenth month after plan year end). What a late Form 5500 costs.
How much did Xeris Pharmaceuticals, Inc. pay in health insurance broker commissions in 2025?
Xeris Pharmaceuticals, Inc.'s 2025 Form 5500 reports $320,364 in broker commissions and fees across 11 insurance contracts ($315,407 in commissions, $4,957 in fees), with Verus Insurance Services, LLC receiving the largest share.
Is Xeris Pharmaceuticals, Inc.'s health plan self-funded or fully insured?
The 2025 filing indicates the plan is a mix of insured and self-funded coverage. Medical coverage is written by Bluecross Blueshield of Illinois.
How does Xeris Pharmaceuticals, Inc.'s broker compensation compare with similar employers?
A commission-to-premium ratio cannot be computed for Xeris Pharmaceuticals, Inc. because the filing does not report medical premium on Schedule A (usual for self-funded plans). In dollars, employers with 200-499 participants that disclosed broker pay reported a median of $77,013.
Send the full findings to your inbox.
A specialist writes up every finding for Xeris Pharmaceuticals, Inc. with the methodology and public-source citations, in a form you can forward to your CFO or counsel. Tick the box if you also want a 15-minute walkthrough call.
We don't sell your email. By submitting, you agree that BenefitsLedger and its benefits advisory partner, WellthCare, may email or call you about these findings. Opt out anytime by replying. See our privacy policy.
Record built October 24, 2026 from U.S. Department of Labor, EBSA Form 5500 datasets (2025, 2024, 2023 plan years, 'Latest' files). Filings can run 7 to 10 months behind the plan year; always confirm against current plan documents. BenefitsLedger is not affiliated with the U.S. Department of Labor. Open the DOL filing search.